Cargando…
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
Regional chemotherapy was first used for lung cancer 30 years ago. Since then, new methods of drug delivery and pharmaceuticals have been investigated in vitro, and in animals and humans. An extensive review of drug delivery systems, pharmaceuticals, patient monitoring, methods of enhancing inhaled...
Autores principales: | Zarogoulidis, Paul, Chatzaki, Ekaterini, Porpodis, Konstantinos, Domvri, Kalliopi, Hohenforst-Schmidt, Wolfgang, Goldberg, Eugene P, Karamanos, Nikos, Zarogoulidis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356182/ https://www.ncbi.nlm.nih.gov/pubmed/22619512 http://dx.doi.org/10.2147/IJN.S29997 |
Ejemplares similares
-
Zarogouldis, P., et al., Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology. Int. J. Mol. Sci. 2012, 13, 10828–10862
por: Zarogoulidis, Paul, et al.
Publicado: (2012) -
Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology
por: Zarogouldis, Paul, et al.
Publicado: (2012) -
Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
por: Domvri, Kalliopi, et al.
Publicado: (2017) -
Vitamin D in asthma and future perspectives
por: Huang, Haidong, et al.
Publicado: (2013) -
Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation
por: Domvri, Kalliopi, et al.
Publicado: (2020)